Skip to main content
Log in

Stabilization of c-myc protein in human glioma cells

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

The regulation of c-myc protein, product of c-myc/genes, was studied in four glioma cell lines by Northern blot, pulse-chase dot blot, immunoblot and immunoprecipitation analyses. Northern blot analysis revealed no overexpression of c-myc transcript, and pulse-chase dot blot analysis showed normal turnover rate of c-myc transcript, suggestive of no evidence of aberrant regulation of c-myc at post-transcriptional level. The synthesis levels of c-myc protein were shown by immunoprecipitation and closely associated with the c-myc transcript levels demonstrated by Northern blot, suggestive of no evidence of aberrant translational control of c-myc, whereas they were dissociated from the accumulation levels of c-myc protein shown by immunoblot, suggestive of an evidence of aberrant regulation of c-myc at post-translational level. The mean (±standard deviation) half-lives of c-myc protein in four glioma cell lines were calculated from the pulse-chase immunoprecipitation analysis, and being 98±8 to 143±11 min, were about four-to sixfold longer than normal. In surgical specimens, the immunostain of c-myc protein was not found in normal astrocytes but localized heterogeneously in nuclei of reactive astrocytes and glioma cells, and increased in stained cell number in proportion to malignancy. Although this study was limited to four glioma cell lines, it suggests that the c-myc protein in glioma cells may be accumulated due to its prolonged half-life contributing to an uncontrolled proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chomosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707–1711

    Google Scholar 

  2. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene amplification in malignant human gliomas: clinical and histopathological aspects. J Neuropathol Exp Neurol 47:191–205

    Google Scholar 

  3. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217

    Google Scholar 

  4. Blanchard JM, Piechaczyk M, Dani C, Chambard JC, Franchi A, Pouyssegur J, Jeanteur P (1985) c-myc gene is transcribed at high rate in Go-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317:443–445

    Google Scholar 

  5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Google Scholar 

  6. Brewer G, Rose J (1989) Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol Cell Biol 9:1996–2006

    Google Scholar 

  7. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

    Google Scholar 

  8. Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361–384

    Google Scholar 

  9. Cory S (1986) Activation of cellular oncogenes in hematopoietic cells by chromosome translocation. Adv Cancer Res 47:189–234

    Google Scholar 

  10. Dani C, Blanchard JM, Piechaczyk M, El-Sabouty S, Marty L, Jeanteur P (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 81:7046–7050

    Google Scholar 

  11. Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE, Campisi J (1986) Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact J Biol Chem 261:9161–9166

    Google Scholar 

  12. Engelhard HH III, Butler AB IV, Bauer KD (1989) Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue. J Neurosurg 71:224–232

    Google Scholar 

  13. Fujimoto M, Sheridan PJ, Sharp ZD, Weaker FJ, Kagan-Hallet KS, Story JL (1989) Proto-oncogene analyses in brain tumors. J Neurosurg 70:910–915

    Google Scholar 

  14. Halazonetis TD, Kandil AN (1991) Determination of the c-MYC DNA-binding site. Proc Natl Acad Sci USA 88:6162–6166

    Google Scholar 

  15. Hann SR, Eisenman RN (1984) Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 4:2486–2497

    Google Scholar 

  16. Hann SR, Thompson CB, Eisenman RN (1985) C-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366–369

    Google Scholar 

  17. Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN (1988) A non-AUG translational initiation in c-myc exon 1 generates in N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185–195

    Google Scholar 

  18. Holte H, Stokke T, Smeland E, Watt R, Blomhoff HK, Kaalhus O, Ohlsson R (1989) Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas. Int J Cancer 43:164–170

    Google Scholar 

  19. Hoshino T, Prados M, Wilson CB, Cho KG, Lee K-S, Davis RL (1989) Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg 71:335–341

    Google Scholar 

  20. Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85:316–322

    Google Scholar 

  21. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610

    Google Scholar 

  22. Kleihues P, Burger PC, Scheithauer BW (1992) Histological typing of tumours of the central nervous system, 2nd edn. Springer Verlag, Berlin Heidelberg New York Tokyo

    Google Scholar 

  23. Kunishio K, Mishima N, Matsuhisa T, Tsuno K, Matsumi N, Satoh T, Matsumoto K, Furuta T, Nishimoto A, Shiraishi T (1990) Immunohistochemical demonstration of DNA polymerase α in human brain tumors. J Neurosurg 72:268–272

    Google Scholar 

  24. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    Google Scholar 

  25. Littlewood TD, Evan GI (1990) The role of myc oncogenes in cell growth and differentiation. Adv Dent Res 4:69–79

    Google Scholar 

  26. Louis DN, Meehan SM, Ferrante RJ, Hedley-Whyte ET (1992) Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 51:150–157

    Google Scholar 

  27. Lüscher B, Eisenman RN (1990) New light on Myc and Myb. I. Myc. Genes Dev 4:2025–2035

    Google Scholar 

  28. Marcu KB (1987) Regulation of expression of the c-myc protooncogene. Bioessays 6:28–32

    Google Scholar 

  29. Miyamoto C, Chizzonite R, Crowl R, Rupprecht K, Kramer R, Shaber M, Kumar G, Poonian M, Ju G (1985) Molecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Sacchromyces cervisiae: comparison of the protein products. Proc Natl Acad Sci USA 82:7232–7236

    Google Scholar 

  30. Moore JP, Hancock DC, Littlewood TD, Evan GI (1987) A sensitive and quantitative enyzme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res 2:65–80

    Google Scholar 

  31. Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF (1992) Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66:106–112

    Google Scholar 

  32. Persson H, Henninghausen L, Taub R, DeGrado W, Leder P (1984) Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science 225:687–693

    Google Scholar 

  33. Plate KH, Rüschoff J, Behke J, Mennel HD (1990) Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity. Acta Neurochir (Wien) 104:103–109

    Google Scholar 

  34. Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH (1985) Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4:2009–2015

    Google Scholar 

  35. Ramsay G, Evan GI, Bishop JM (1984) The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci USA 81:7742–7746

    Google Scholar 

  36. Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541–544

    Google Scholar 

  37. Shindo H, Tani E, Kochi N, Kaba K, Matsumoto T, Miyaji K, Yamamoto Y, Furuyama J (1991) Interspecies comparison of c-myc gene in human and rat glioma cell lines. Acta Neuropathol 81:382–387

    Google Scholar 

  38. Spector DL, Watt RA, Sullivan NF (1987) The v- and c-myc oncogene proteins co-localize in situ with small nuclear ribonucleoprotein particles. Oncogene 1:5–12

    Google Scholar 

  39. Swartwout SG, Kinniburgh AJ (1989) c-myc RNA degradation in growing and differentiating cells: possible alternate pathways. Mol Cell Biol 9:288–295

    Google Scholar 

  40. Swartwout SG, Preisler H, Guan WD, Kinniburgh AJ (1987) Relatively stable population of c-myc RNA that lacks long poly (A). Mol Cell Biol 7:2052–2058

    Google Scholar 

  41. Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76:792–798

    Google Scholar 

  42. Thompson CB, Challoner PB, Neiman PE, Groudine M (1985) Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314:363–366

    Google Scholar 

  43. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470–473

    Google Scholar 

  44. Weinstein IB (1987) Growth factors, oncogenes, and multistage carcinogenesis. J Cell Biochem 33:213–224

    Google Scholar 

  45. Wingrove TG, Watt R, Keng P, Macara IG (1988) Stabilization of myc proto-oncogene proteins during Friend murine erythroleukemia cell differentiation. J Biol Chem 263:8918–8924

    Google Scholar 

  46. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899–6903

    Google Scholar 

  47. Zülch KJ (1979) Histological typing of tumours of the central nervous system. World Health Organization, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Research Grant from the Hyogo College of Medicine

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shindo, H., Tani, E., Matsumuto, T. et al. Stabilization of c-myc protein in human glioma cells. Acta Neuropathol 86, 345–352 (1993). https://doi.org/10.1007/BF00369446

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00369446

Key words

Navigation